Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$88,498,817
+$40,023,347 QoQ
Shares Held
2,500,673
+42.9% QoQ
Ownership
0.346%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#45
of 489 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ROIV ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
This page
|
2,500,673 | $88,498,817 |
All Filings in ROIV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,498,817 | 2,500,673 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $48,475,470 | 1,750,017 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $37,975,368 | 1,750,017 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $46,382,376 | 3,065,590 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $45,080,371 | 4,000,033 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $53,006,362 | 5,253,356 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $72,540,944 | 6,131,948 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $100,241,933 | 8,686,476 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $84,569,925 | 8,000,939 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $117,756,105 | 11,172,306 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $69,084,343 | 6,151,767 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $83,795,275 | 7,174,253 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $38,272,459 | 3,796,871 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $26,276,866 | 3,560,551 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $37,600,820 | 4,705,985 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,047,858 | 2,499,335 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||